Medicare Price Talks Progress As Drug Companies Make Counteroffers

Negotiations over 10 Medicare Part D drugs are slated to end in August, with newly negotiated rates announced in September.

Stethoscope with $100 bills attached, over blue background
(Image credit: Juan Moyano, Getty Images)

Medicare's efforts to get drugmakers to reduce prices of the first 10 Part D drugs selected under the Medicare Drug Price Negotiation Program are progressing.

The 10 drugmakers participating in the talks sent counteroffers to the agency earlier this week, following its initial offer on February 1.

Subscribe to Kiplinger’s Personal Finance

Be a smarter, better informed investor.

Save up to 74%

Sign up for Kiplinger’s Free E-Newsletters

Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.

Profit and prosper with the best of expert advice - straight to your e-mail.

Sign up

To continue reading this article
please register for free

This is different from signing in to your print subscription

Why am I seeing this? Find out more here

Esther D’Amico
Senior News Editor

Esther D’Amico is Kiplinger’s senior news editor. A long-time antitrust and congressional affairs journalist, Esther has covered a range of beats including infrastructure, climate change and the industrial chemicals sector. She previously served as chief correspondent for a financial news service where she chronicled debates in and out of Congress, the Department of Justice, the Federal Trade Commission and the Commerce Department with a particular focus on large mergers and acquisitions. She holds a bachelor’s degree in journalism and in English.

With contributions from